Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II.

Saved in:
Bibliographic Details
Title: Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II.
Authors: Yoshikawa T; Medical Systems Research and Development Center, FUJIFILM Corporation, Amagasaki, JPN., Ohtsubo T; Medical Systems Research and Development Center, FUJIFILM Corporation, Amagasaki, JPN., Yamaguchi I; Medical Systems Research and Development Center, FUJIFILM Corporation, Amagasaki, JPN., Nishihara H; Diagnostics Technical Service and Department Operations, FUJIFILM Wako Pure Chemical Corporation, Osaka, JPN., Mori Y; Diagnostics Technical Service and Department Operations, FUJIFILM Wako Pure Chemical Corporation, Osaka, JPN., Yamada H; Medical Systems Business Division, FUJIFILM Corporation, Tokyo, JPN., Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, JPN., Kawabata T; Diagnostics Technical Service and Department Operations, FUJIFILM Wako Pure Chemical Corporation, Osaka, JPN., Matsuda S; Medical Systems Research and Development Center, FUJIFILM Corporation, Amagasaki, JPN.
Source: Cureus [Cureus] 2026 Feb 17; Vol. 18 (2), pp. e103793. Date of Electronic Publication: 2026 Feb 17 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-8184
DOI:10.7759/cureus.103793